Llwytho...
Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update
Immunotherapy represents one of the most promising therapeutic approaches in lung cancer, however 50% of lung cancer patients will not respond to this treatment, while others will have transitory or durable responses. Because side effects may be life threatening and treatment costs remain very high,...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Thorac Dis |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
AME Publishing Company
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353739/ https://ncbi.nlm.nih.gov/pubmed/30775025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.48 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|